NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. Patients are currently being enrolled in a clinical trial of the company's Responsive Neurostimulator (RNS™) system for treating medically refractory epilepsy.
NeuroPace Address
455 N. Bernardo Avenue Mountain View, CA United States